KLOW – GHK-Cu / BPC-157 / TB-500 / KPV

KLOW Blend is a multi-peptide formulation containing GHK-Cu 50mg, TB-500 10mg, BPC-157 10mg, and KPV 10mg, supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into peptide synergy, structural interaction, and signalling pathways.

Classification: Four-peptide research blend: GHK-Cu, BPC-157, TB-500 and KPV (a tripeptide fragment Lys-Pro-Val derived from the C-terminus of α-MSH).

Within laboratory settings, KLOW Blend is studied for the combined interaction of GHK-Cu, TB-500, BPC-157, and KPV across multiple biological pathways. Research applications focus on receptor activity, peptide stability, and the behaviour of combined peptide systems under controlled experimental conditions.

This summary describes published preclinical and, where applicable, clinical research. It is not a medical claim and does not describe or endorse any human use of the compound as sold by Peptides UK 4U.

As with GLOW, each component is studied separately. KPV adds a fragment of α-melanocyte-stimulating hormone investigated in preclinical inflammatory-signalling research. All references below are single-agent studies; combination pharmacology is not established.

This product is typically reconstituted using bacteriostatic water or a suitable sterile solvent within a controlled laboratory setting. All handling should be carried out by qualified professionals using appropriate sterile techniques and safety procedures.

Storage & stability

• Store in a cool, dry environment before reconstitution.
• For extended stability, storage at -20°C is recommended.
• Avoid repeated freeze-thaw cycles after reconstitution.

For reconstitution volumes and target working concentrations use our peptide calculator. We do not publish dosing protocols for human use.

Peptide Type

Multi-peptide blend

Key Components

GHK-Cu 50mg, TB-500 10mg, BPC-157 10mg, KPV 10mg

Form

Lyophilised powder

Composition

Multi-component peptide formulation

Purity

≥98% (subject to batch testing)

Appearance

Light blue/purple lyophilised powder

Solubility

Water soluble

Stability

Maintains integrity under controlled storage conditions

Manufacturing Standard

Produced in controlled laboratory environments

Certificate of Analysis: Available on request from our support team.

• Pickart L et al., Oxidative Medicine and Cellular Longevity 2015:648108 — GHK-Cu
• Sikirić P et al., Current Pharmaceutical Design 20(7):1126–1135 (2014) — BPC-157
• Goldstein AL et al., Annals of the NY Academy of Sciences 1112:1–14 (2007) — thymosin β4
• Brzoska T et al., Endocrine Reviews 29(5):581–602 (2008) — α-MSH and KPV signalling

References are provided for educational context. Citation does not imply endorsement of any specific use.